Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Neuroendocrine

Clinical trial condition

Carcinoma, Neuroendocrine

Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.

109 public trials 31 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Neuroendocrine trial results

Not Yet Recruiting

Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

NCT07192991

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma

NCT07156019

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

NCT07014540

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS)

NCT06816394

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: National Taiwan University Hospital Taipei, Please Select, Taiwan

View Trial Details

Completed

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

NCT00113360

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +17 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT01642251

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations: Loma Linda University Medical Center Loma Linda, California, United States

Stanford Cancer Institute Palo Alto Palo Alto, California, United States

Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States

The Medical Center of Aurora Aurora, Colorado, United States

View all 428 locations

View Trial Details

Completed

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT05461430

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +139 more
Locations: xCures Oakland, California, United States

View Trial Details

Completed

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

NCT04069299

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: H Lee Moffitt Cancer & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors

NCT03290079

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer

NCT02820857

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Sud, CHU d'Amiens Amiens, France

Service d'Hépatogastroentérologie, CHU d'Angers Angers, France

Service d'Oncologie et Radiothérapie, Institut Sainte Catherine Avignon, France

Service de Gastroentérologie et Oncologie Digestive, Hôpital Avicenne Bobigny, France

View all 26 locations

View Trial Details